Matthew Milowsky
University of North Carolina At Chapel Hill

Last Updated On 2/3/2023 12:34:28 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
Company: Pfizer
Recipient: You
Company: Merck
Recipient: You
Company: Gilead Sciences
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Loxo/Lilly
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Merck
Recipient: Your Institution
Company: Roche/Genentech
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Mirati Therapeutics
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: Seagen
Recipient: Your Institution
Company: G1 Therapeutics
Recipient: Your Institution
Company: Alliance Foundation Trials
Recipient: Your Institution
Company: Alliance for Clinical Trials in Oncology
Recipient: Your Institution
Company: Clovis Oncology
Recipient: Your Institution
Company: Arvinas
Recipient: Your Institution
Company: ALX Oncology
Recipient: Your Institution
Company: Loxo
Recipient: Your Institution
Company: Hoosier Cancer Research Network
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
Company: Elsevier
Recipient: You
Company: Medscape
Recipient: You

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered